期刊文献+

高密度脂蛋白胆固醇与冠状动脉疾病及高血压的关系 被引量:4

Correlation of high density cholesterol levels and coronary artery diseases and hypertension
下载PDF
导出
摘要 目的研究高密度脂蛋白胆固醇(HDL-C)水平与冠状动脉疾病(CAD)及高血压的关系。方法随机抽取HDL-C>2.6mmol/L的102例患者为研究对象,收集与CAD发病相关的年龄、性别、体重、身高及吸烟、酒精摄入、饮食习惯、运动、慢性病史、药物治疗、绝经、动脉粥样硬化(AS)家庭史等资料,并将患者分为高血压组与血压正常进行统计学分析。结果年龄、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白(LDL)、HDL、体重指数、吸烟、酒精摄入及运动等因素的差异无显著性意义(P>0.05);而在CAD、糖尿病(d iabetesm ellitus,DM)、脑血管意外发病率方面差异具有显著性意义(P<0.05)。结论HDL-C为心血管病的一种保护性因子,HDL-C水平降低,则CAD及高血压病的发病率升高。 Objective To explore the relationship between high density lipoprotein cholesterol (HDL- C ) levels and coronary artery diseases (CAD) and hypertension. Methods One hundred and two patients with HDL -C 〉 2. 6mmol/ L were admitted randomly. Data of age, sex, body weight, height and smoking, alcohol, diets, exercises, chronic disease history, medication, menopause, atherosclerosis (AS) family history, etc. that of relationship with CAD were collected. Statistic analysis was performed according to the clinical features of hypertension group and nonhypertension group. Results There was non - significantly ( P 〉 0.05 ) in age, triglycerides (TG) , total cholestreos ( TC ) , low density lipoprotein (LDL), HDL, body mass index, smlking, etc. ; and there was significantly ( P 〈 0.05) in incidence rate of CAD, diabetes meUitus (DM) , and cerebrovascular accident. Conclusion HDL - C was a protection factor of cardiovascular diseases. The more lower of HDL - C levels, and the more high incidence rate of CAD and hypertension.
出处 《邯郸医学高等专科学校学报》 2005年第4期279-281,共3页 Journal of Handan Medical College
关键词 高密度脂蛋白胆固醇 冠状动脉疾病 高血压 HDL- C CAD Hypertension
  • 相关文献

参考文献12

二级参考文献23

  • 1刘静,吴兆苏,张瑞松,刘军,秦兰萍.体重指数、腰围/臀围比与血压、血脂的相关性[J].心肺血管病杂志,1995,14(4):214-218. 被引量:22
  • 2李莹,周北凡,郭敏,刘冬海.大规模多中心协作研究中血脂测定的标准化[J].中国慢性病预防与控制,1996,4(4):173-176. 被引量:9
  • 3Channon KM,Clegg RJ ,Bhatnagar D, et al. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer [J]. Atherosclerosis,1990,80(3) :217-226.
  • 4Hirano K, Yamashita S, Matsuzawa Y. Pros and cons of inhibiting cholesteryl ester transfer protein[J]. Curr Opin Lipidol,2000,11 (6) :589-596.
  • 5Akita H,Chiba H, Hui SP, et al. Cholesteryl ester transfer protein deficiency: identification in the Chinese EJ]. Am J Med Genet, 1995,59 : 399-400.
  • 6Kuivenhoven JA,de Knijff P,Boer JM, et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels E J]. Arterioscler Thromb Vasc Biol, 1997,17(3):560-568.
  • 7Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels[J]. J Clin Invest,1996,97(12) :2917-2923.
  • 8Hirano K,Yamashita S,Nakajima N, et al. Genetic eholestery ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipopro-teinemia caused by CETP gene mutation is not associated with longevity[J]. Arterioscler Thromb Vasc Biol, 1997,17(6): 1053-1059.
  • 9Tall AR. Plasma cholesteryl ester transfer protein and highdensity lipoprotein: new insights from molecular genetic studies[J]. J Intern Med, 1995,237(1): 5-12.
  • 10Yamashita S, Hirano K, Sakai N, et al. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein[J]. Biochim Biophys Acta, 2000, 1529 (1-3) :257-275.

共引文献281

同被引文献22

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部